Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.200
+0.160 (5.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Tvardi Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 30 | 40 | - | - | - |
| Enterprise Value | -1 | 4 | - | - | - |
| Last Close Price | 3.20 | 4.30 | - | - | - |
| PB Ratio | 1.43 | 1.93 | - | - | - |
| P/TBV Ratio | 1.46 | 1.96 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | -5.43 | 0.02 | 0.01 |
| Net Debt / Equity Ratio | -1.46 | -1.46 | 0.19 | -0.96 | -1.07 |
| Net Debt / EBITDA Ratio | 1.15 | 1.15 | 0.04 | 1.21 | 2.05 |
| Net Debt / FCF Ratio | 1.30 | 1.30 | 0.06 | 1.07 | 2.42 |
| Quick Ratio | 2.79 | 2.79 | 3.05 | 6.99 | 10.23 |
| Current Ratio | 2.86 | 2.86 | 3.06 | 7.97 | 10.31 |
| Return on Equity (ROE) | -237.81% | -237.81% | -329.99% | -54.30% | - |
| Return on Assets (ROA) | -49.70% | -49.70% | -56.48% | -32.36% | - |
| Return on Capital Employed (ROCE) | -127.20% | -127.20% | -113.20% | -78.70% | -51.90% |
| Earnings Yield | -60.67% | -45.15% | - | - | - |
| FCF Yield | -78.28% | -58.25% | - | - | - |
| Buyback Yield / Dilution | -202.35% | -202.35% | 59.64% | -0.09% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.